The latter concept has been purported to explain why a subset of individuals with cerebrotendinous xanthomatosis (CTX) due to loss-of-function mutations in cyp27a1 are at increased risk of developing atherosclerosis despite normal levels of circulating cholesterol11,41,42. The gene discussed is CYP27A1; the disease is cerebrotendinous xanthomatosis.